Vindrieux David, Gras Baptiste, Garcia-Belinchon Merce, Mourah Samia, Lebbe Céleste, Augert Arnaud, Bernard David
Inserm U1052, Centre de Recherche en Cancérologie de Lyon, Lyon, F-69000, France.
Aging (Albany NY). 2013 Jul;5(7):531-8. doi: 10.18632/aging.100577.
Normal cells enter a senescent state upon aberrant oncogenic signals and this response inhibits tumor initiation and progression. It is now well admitted that intracellular and membrane localized oncogenes can illicit oncogene induced senescence. However, the effect of mitogenic growth factor on cellular senescence is so far largely unknown. Here we show that normal human dermal fibroblasts display a complex response to Platelet derived growth factor B (PDGFB) expression. Indeed, PDGFB expression induces, in the same cell population, both senescence and cellular transformation. Remarkably both populations are sustained with passages suggesting that transformed cells eventually enter a senescent state. This senescence state is p53 dependent as inhibiting the p53 pathway blocks the ability of PDGFB to induce senescence and results in strong cellular transformation increase upon PDGFB expression. The relevance of these observations is supported by the fact that human dermatofibrosarcoma protuberans, skin tumors arising from constitutive PDGFB production with little aggressiveness, also display some senescence hallmarks. Together these data support the view that PDGFB, a mitogenic growth factor, has a limited ability to induce senescence. We propose that this low level of senescence might decrease the transforming ability of this factor without totally abolishing it.
正常细胞在异常致癌信号作用下进入衰老状态,这种反应可抑制肿瘤的起始和进展。目前人们普遍认为,细胞内和膜定位的癌基因可引发癌基因诱导的衰老。然而,有丝分裂原性生长因子对细胞衰老的影响迄今仍 largely 未知。在此我们表明,正常人皮肤成纤维细胞对血小板衍生生长因子 B(PDGFB)的表达表现出复杂的反应。事实上,PDGFB 的表达在同一细胞群体中既诱导衰老又诱导细胞转化。值得注意的是,这两种细胞群体都随着传代而持续存在,这表明转化细胞最终会进入衰老状态。这种衰老状态依赖于 p53,因为抑制 p53 途径会阻断 PDGFB 诱导衰老的能力,并导致在 PDGFB 表达时细胞转化显著增加。人隆突性皮肤纤维肉瘤(一种由持续性 PDGFB 产生引起的侵袭性较小的皮肤肿瘤)也表现出一些衰老特征,这一事实支持了这些观察结果的相关性。这些数据共同支持了这样一种观点,即有丝分裂原性生长因子 PDGFB 诱导衰老的能力有限。我们提出,这种低水平的衰老可能会降低该因子的转化能力,但不会完全消除它。